Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B

被引：0
|
作者：
Lei Diao
Shuanglian Li
Thomas Ludden
Jogarao Gobburu
Ivan Nestorov
Haiyan Jiang
机构：
[1] Biogen Idec,Department of Pharmacy Practice and Science, Center for Translational Medicine, School of Pharmacy
[2] University of Maryland,undefined
来源：
Clinical Pharmacokinetics | 2014年 / 53卷
关键词：
Validation Dataset; Population Pharmacokinetic Model; Online Resource Table; Population Pharmacokinetic Analysis; Objective Function Value;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：467 / 477
页数：10
相关论文
共 50 条
  • [1] Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
    Diao, Lei
    Li, Shuanglian
    Ludden, Thomas
    Gobburu, Jogarao
    Nestorov, Ivan
    Jiang, Haiyan
    CLINICAL PHARMACOKINETICS, 2014, 53 (05) : 467 - 477
  • [2] Population pharmacokinetic analysis of a long-acting recombinant factor IX-FC fusion protein (RFIXFC) in patients with severe haemophilia B
    Diao, L.
    Li, S.
    Nestorov, I.
    Jiang, H.
    HAEMOPHILIA, 2013, 19 : 33 - 33
  • [3] Population pharmacokinetic modelling of factor IX activity after administration of recombinant factor IX in patients with haemophilia B
    Suzuki, A.
    Tomono, Y.
    Korth-Bradley, J. M.
    HAEMOPHILIA, 2016, 22 (05) : E359 - E366
  • [4] A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B
    Koopman, Sjoerd F.
    Goedhart, Tine M. H. J.
    Bukkems, Laura H.
    Mulders, Trevor M.
    Leebeek, Frank W. G.
    Fijnvandraat, Karin
    Coppens, Michiel
    Mathias, Mary
    Collins, Peter W.
    Tait, R. Campbell
    Bagot, Catherine N.
    Curry, Nicola
    Payne, Jeanette
    Chowdary, Pratima
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 220 - 231
  • [5] Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B
    Pasi, K. John
    Fischer, Kathelijn
    Ragni, Margaret
    Nolan, Beatrice
    Perry, David J.
    Kulkarni, Roshni
    Ozelo, Margareth
    Mahlangu, Johnny
    Shapiro, Amy D.
    Baker, Ross I.
    Bennett, Carolyn M.
    Barnes, Christopher
    Oldenburg, Johannes
    Matsushita, Tadashi
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    Mei, Baisong
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (03) : 508 - 518
  • [6] Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B
    Wang, C.
    Young, G.
    HAEMOPHILIA, 2018, 24 (03) : 414 - 419
  • [7] Assessment of recombinant factor IX-FC fusion protein (RFIXFC) clotting activity in plasma samples at canadian haemophilia treatment centres
    Geske, Jon F.
    Sadeghi-Khomami, A.
    Chaudhry, H. R.
    Sholzberg, M.
    Teitel, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 316 - 316
  • [8] Individualised Prophylaxis with Recombinant Factor IX FC Fusion Protein (RFIXFC) in Adults/Adolescents With Haemophilia B: Updated Interim Results of the B-YOND Extension Study
    Mahlangu, J. N.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ferrante, F.
    Ramirez-Santiago, A.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 85 - 86
  • [9] Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
    Powell, Jerry S.
    Apte, Shashikant
    Chambost, Herve
    Hermans, Cedric
    Jackson, Shannon
    Josephson, Neil C.
    Mahlangu, Johnny N.
    Ozelo, Margareth C.
    Peerlinck, Kathelijne
    Pasi, John
    Perry, David
    Ragni, Margaret V.
    Wang, Xuefeng
    Jiang, Haiyan
    Li, Shuanglian
    Cristiano, Lynda M.
    Innes, Alison
    Nugent, Karen
    Brennan, Aoife
    Luk, Alvin
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 124 - 134
  • [10] Subject-Reported Changes in Physical Activity During The B-LONG Study of Recombinant Factor IX FC Fusion Protein (RFIXFC) For Severe Haemophilia B
    Windyga, J.
    Ragni, M.
    Pasi, J.
    Shapiro, A. D.
    Ozelo, M.
    Innes, A.
    Mei, B.
    HAEMOPHILIA, 2015, 21 : 29 - 29
12345